New research reveals ketamine's safe use for treating eating disorders, offering hope for patients with comorbid treatment-resistant depression.
Elizabeth Wassenaar, MD, MS, CEDS-S, DFAPA
Advertisement
Articles by Elizabeth Wassenaar, MD, MS, CEDS-S, DFAPA
An expert discusses this comorbidity, plus the effects of semaglutide and other GLP-1 agonists on this patient population.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Preliminary Report on Dangers of AI Chatbots
2
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
3
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
